Cargando…

Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway

Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yu, Rahmanto, Yohan Suryo, Lee, Meng-Horng, Wu, Pei-Hsun, Phillip, Jude M., Huang, Chuan-Hsiang, Vitolo, Michele I., Gaillard, Stephanie, Martin, Stuart S., Wirtz, Denis, Shih, Ie-Ming, Wang, Tian-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043408/
https://www.ncbi.nlm.nih.gov/pubmed/29643476
http://dx.doi.org/10.1038/s41388-018-0241-0
_version_ 1783339278345961472
author Yu, Yu
Rahmanto, Yohan Suryo
Lee, Meng-Horng
Wu, Pei-Hsun
Phillip, Jude M.
Huang, Chuan-Hsiang
Vitolo, Michele I.
Gaillard, Stephanie
Martin, Stuart S.
Wirtz, Denis
Shih, Ie-Ming
Wang, Tian-Li
author_facet Yu, Yu
Rahmanto, Yohan Suryo
Lee, Meng-Horng
Wu, Pei-Hsun
Phillip, Jude M.
Huang, Chuan-Hsiang
Vitolo, Michele I.
Gaillard, Stephanie
Martin, Stuart S.
Wirtz, Denis
Shih, Ie-Ming
Wang, Tian-Li
author_sort Yu, Yu
collection PubMed
description Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombinant SYK directly phosphorylates cortactin and cofilin, which are critically involved in assembly and dynamics of actin filament through phosphorylation signaling. Enhancing SYK activity by inducing expression of a constitutively active SYK mutant, SYK(130E), increased growth factor-stimulated migration and invasion of ovarian cancer cells, which was abrogated by cortactin knockdown. Similarly, SYK inhibitors significantly decreased invasion of ovarian cancer cells through basement membrane matrix in a real-time transwell assays and in a 3-D tumor spheroid model. SYK inactivation by gene knockout or by small molecule inhibition reduced actin polymerization. Collectively, the results reported here identify a new mechanism by which SYK signaling regulates ovarian cancer cell motility and invasiveness, and pinpoint a target-based strategy to prevent or suppress the advancement of ovarian malignancies.
format Online
Article
Text
id pubmed-6043408
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-60434082018-10-11 Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway Yu, Yu Rahmanto, Yohan Suryo Lee, Meng-Horng Wu, Pei-Hsun Phillip, Jude M. Huang, Chuan-Hsiang Vitolo, Michele I. Gaillard, Stephanie Martin, Stuart S. Wirtz, Denis Shih, Ie-Ming Wang, Tian-Li Oncogene Article Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombinant SYK directly phosphorylates cortactin and cofilin, which are critically involved in assembly and dynamics of actin filament through phosphorylation signaling. Enhancing SYK activity by inducing expression of a constitutively active SYK mutant, SYK(130E), increased growth factor-stimulated migration and invasion of ovarian cancer cells, which was abrogated by cortactin knockdown. Similarly, SYK inhibitors significantly decreased invasion of ovarian cancer cells through basement membrane matrix in a real-time transwell assays and in a 3-D tumor spheroid model. SYK inactivation by gene knockout or by small molecule inhibition reduced actin polymerization. Collectively, the results reported here identify a new mechanism by which SYK signaling regulates ovarian cancer cell motility and invasiveness, and pinpoint a target-based strategy to prevent or suppress the advancement of ovarian malignancies. 2018-04-11 2018-07 /pmc/articles/PMC6043408/ /pubmed/29643476 http://dx.doi.org/10.1038/s41388-018-0241-0 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Yu, Yu
Rahmanto, Yohan Suryo
Lee, Meng-Horng
Wu, Pei-Hsun
Phillip, Jude M.
Huang, Chuan-Hsiang
Vitolo, Michele I.
Gaillard, Stephanie
Martin, Stuart S.
Wirtz, Denis
Shih, Ie-Ming
Wang, Tian-Li
Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title_full Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title_fullStr Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title_full_unstemmed Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title_short Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
title_sort inhibition of ovarian tumor cell invasiveness by targeting syk in tyrosine kinase signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043408/
https://www.ncbi.nlm.nih.gov/pubmed/29643476
http://dx.doi.org/10.1038/s41388-018-0241-0
work_keys_str_mv AT yuyu inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT rahmantoyohansuryo inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT leemenghorng inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT wupeihsun inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT phillipjudem inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT huangchuanhsiang inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT vitolomichelei inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT gaillardstephanie inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT martinstuarts inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT wirtzdenis inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT shihieming inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway
AT wangtianli inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway